Rosemont Pharmaceuticals Limited

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours e-mail: pharmacovigilance@rosemontpharma.com
Out of Hours e-mail: +44 (0)7836 557 879
Patient Information Leaflet last updated on the eMC: 28/10/2009
PIL Amilamont 5mg/5ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/01/2009 and displayed until 28/10/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/05/2008 and displayed until 26/01/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 02/08/2007 and displayed until 13/05/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 25/09/2002 and displayed until 02/08/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   amiloride hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk